Regeneron’s REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients

TARRYTOWN, N.Y., Sept. 29, 2020 /PRNewswire/ —  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19. REGN-COV2 also showed positive trends in reducing medical visits. The ongoing, randomized, double-blind trial […]

Read more

U.S. FDA Approves Pfizer’s Xeljanz (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis

NEW YORK–(BUSINESS WIRE) September 28, 2020 — Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved Xeljanz® (tofacitinib) for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA). Two formulations were approved, a tablet and an oral solution, and are dosed based upon […]

Read more

FDA Approves Qdolo

FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management of pain severe enough to […]

Read more

Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments

NEW BRUNSWICK, N.J., February 18, 2020 – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health & Human Services, to seek treatment solutions for COVID-19, the disease caused […]

Read more

Current statin use may lower risk for lethal prostate cancer

(HealthDay)—Current statin use is inversely associated with the risk for lethal prostate cancer, according to a study published online Nov. 21 in Clinical Cancer Research. Emma H. Allott, Ph.D., from Queen’s University Belfast in the United Kingdom, and colleagues prospectively examined statin use and lethal prostate cancer risk in the Health Professionals Follow-up Study. Data were included for 44,126 men […]

Read more

Bladder cancer treatment rejected for routine use on NHS in England

An immunotherapy treatment for some people with bladder cancer, currently available through the Cancer Drugs Fund, has been given an initial “no” for routine use in England. Pembrolizumab (Ketruda) will continue to be available as a treatment option on the NHS until at least January 2020, when the National Institute for Health and Care Excellence (NICE) reviews this initial decision.  In […]

Read more

FDA sends warning letter about foreign OTC drugs to Dollar Tree

Dollar Tree has been sent a warning letter for selling over-the-counter (OTC) drugs made by foreign companies with serious, multiple violations of federal manufacturing laws, the U.S. Food and Drug Administration says. The drugs include Dollar Tree’s Assured Brand OTC drugs and other drug products sold by Dollar Tree Co., which operates stores under the Dollar Tree and Family Dollar […]

Read more

Study finds new option for liver transplant patients

A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication for liver transplant patients leading to fewer serious side effects than the most commonly used therapy, according to a University of Cincinnati researcher. Dr. Khurram Bari, an associate professor in the UC Division of Digestive Diseases, explains the […]

Read more

Most physicians treating STIs do not have meds on hand

Most office-based physicians who provide sexually transmitted infections (STIs) services report not having on-site access to the recommended injectable medications for same-day treatment of gonorrhea and syphilis, according to a research letter published in the November issue of Emerging Infectious Diseases, a publication of the U.S. Centers for Disease Control and Prevention. William S. Pearson, Ph.D., from the CDC in […]

Read more

Five key things about fentanyl and America’s opioids crisis

Jury selection has begun in a landmark federal case on Ohio on whether drug companies can be held responsible for the opioids epidemic that is raging across America. The case is seen as a test for the entire pharmaceuticals industry, which stands accused of fueling the crisis by aggressively promoting painkillers that can become dangerously addictive. Perhaps predictably, the companies […]

Read more
1 2 3 5